Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Marcel J R, Janssen"'
Autor:
Meike W. M. van Wijk, Gerhard van Wolfswinkel, Mark J. Arntz, Marcel J. R. Janssen, Joey Roosen, J. Frank W. Nijsen
Publikováno v:
EJNMMI Physics, Vol 11, Iss 1, Pp 1-14 (2024)
Abstract Background To develop and validate a novel administration device for holmium-166 transarterial radioembolisation (TARE) with the purpose of facilitating controlled fractional microsphere administration for a more flexible and image-guided TA
Externí odkaz:
https://doaj.org/article/c4836bc713084de6afe7059853b2ff54
Autor:
Katrin Rabold, Martijn Zoodsma, Inge Grondman, Yunus Kuijpers, Manita Bremmers, Martin Jaeger, Bowen Zhang, Willemijn Hobo, Han J. Bonenkamp, Johannes H. W. de Wilt, Marcel J. R. Janssen, Lenneke A. M. Cornelissen, Ilse C. H. van Engen-van Grunsven, Willem J. M. Mulder, Jan W. A. Smit, Gosse J. Adema, Mihai G. Netea, Yang Li, Cheng-Jian Xu, Romana T. Netea-Maier
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-14 (2022)
Myeloid cells contribute to the tumor microenvironment of thyroid cancers, but their functional relevance is lesser known. Here authors show that myeloid cells infiltrating non-medullary thyroid carcinomas upregulate their antigen presentation-relate
Externí odkaz:
https://doaj.org/article/8df2ed731e6144a6a49c050153ca4af0
Autor:
Bastiaan M. Privé, Marcel J. R. Janssen, Inge M. van Oort, Constantijn H. J. Muselaers, Marianne A. Jonker, Willemijn A. van Gemert, Michel de Groot, Harm Westdorp, Niven Mehra, J. Fred Verzijlbergen, Tom W. J. Scheenen, Patrik Zámecnik, Jelle O. Barentsz, Martin Gotthardt, Walter Noordzij, Wouter V. Vogel, Andries M. Bergman, Henk G. van der Poel, André N. Vis, Daniela E. Oprea-Lager, Winald R. Gerritsen, J. Alfred Witjes, James Nagarajah
Publikováno v:
Trials, Vol 22, Iss 1, Pp 1-4 (2021)
Abstract Background The BULLSEYE trial is a multicenter, open-label, randomized controlled trial to test the hypothesis if 177Lu-PSMA is an effective treatment in oligometastatic hormone-sensitive prostate cancer (oHSPC) to prolong the progression-fr
Externí odkaz:
https://doaj.org/article/d0eae2f7bc184b94b9f6863ede0c30e8
Autor:
Bastiaan M. Privé, Marcel J. R. Janssen, Inge M. van Oort, Constantijn H. J. Muselaers, Marianne A. Jonker, Michel de Groot, Niven Mehra, J. Fred Verzijlbergen, Tom W. J. Scheenen, Patrik Zámecnik, Jelle O. Barentsz, Martin Gotthardt, Walter Noordzij, Wouter V. Vogel, Andries M. Bergman, Henk G. van der Poel, André N. Vis, Daniela E. Oprea-Lager, Winald R. Gerritsen, J. Alfred Witjes, James Nagarajah
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-9 (2020)
Abstract Background In recent years, there is increasing evidence showing a beneficial outcome (e.g. progression free survival; PFS) after metastases-directed therapy (MDT) with external beam radiotherapy (EBRT) or targeted surgery for oligometastati
Externí odkaz:
https://doaj.org/article/05ea3477df904c7e9eba15f0eafa2c79
Autor:
Jeroen H. A. Creemers, Maarten J. van der Doelen, Sandra van Wilpe, Rick Hermsen, Tjitske Duiveman-de Boer, Diederik M. Somford, Marcel J. R. Janssen, J. P. Michiel Sedelaar, Niven Mehra, Johannes Textor, Harm Westdorp
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
BackgroundRadium-223 improves overall survival (OS) in men with bone metastatic castration-resistant prostate cancer (mCRPC). While the exact mechanism behind this survival benefit remains unclear, radium-induced immunological mechanisms might contri
Externí odkaz:
https://doaj.org/article/9681b271f3804ad081b66ebff52e0e79
Autor:
Yvette J. E. Sloot, Marcel J. R. Janssen, Antonius E. van Herwaarden, Robin P. Peeters, Romana T. Netea-Maier, Johannes W. A. Smit
Publikováno v:
Scientific Reports, Vol 9, Iss 1, Pp 1-7 (2019)
Abstract Sufficient thyroid iodine uptake is needed to ensure effective radioactive iodine (RAI) treatment, which is mediated by the sodium-iodide symporter (NIS). Activation of AMP-activated-protein-kinase (AMPK), leads to decreased NIS expression a
Externí odkaz:
https://doaj.org/article/8cbde1386042484b97308c46c706c4ac
Publikováno v:
Acta obstetricia et gynecologica Scandinavica, 102(1), 105-113. Wiley-Blackwell
Acta Obstetricia et Gynecologica Scandinavica, 102, 105-113
Acta Obstetricia et Gynecologica Scandinavica, 102, 1, pp. 105-113
Acta Obstetricia et Gynecologica Scandinavica, 102, 105-113
Acta Obstetricia et Gynecologica Scandinavica, 102, 1, pp. 105-113
Contains fulltext : 291074.pdf (Publisher’s version ) (Open Access) INTRODUCTION: In the Netherlands, the sentinel lymph node procedure protocol consists of preoperative lymphoscintigraphy combined with intraoperative blue dye for identifying senti
Autor:
Joey Roosen, Meike W. M. van Wijk, Lovisa E. L. Westlund Gotby, Mark J. Arntz, Marcel J. R. Janssen, Daphne Lobeek, Gerrit H. van de Maat, Christiaan G. Overduin, J. Frank W. Nijsen
Publikováno v:
Medical Physics. 50:935-946
Autor:
Joey Roosen, Lovisa E. L. Westlund Gotby, Mark J. Arntz, Jurgen J. Fütterer, Marcel J. R. Janssen, Mark W. Konijnenberg, Meike W. M. van Wijk, Christiaan G. Overduin, J. Frank W. Nijsen
Publikováno v:
European Journal of Nuclear Medicine and Molecular Imaging, 49(13), 4705-4715. Springer-Verlag
European Journal of Nuclear Medicine and Molecular Imaging, 49, 4705-4715
European Journal of Nuclear Medicine and Molecular Imaging, 49, 13, pp. 4705-4715
European Journal of Nuclear Medicine and Molecular Imaging, 49, 4705-4715
European Journal of Nuclear Medicine and Molecular Imaging, 49, 13, pp. 4705-4715
Purpose Transarterial radioembolization (TARE) is a treatment for liver tumours based on injection of radioactive microspheres in the hepatic arterial system. It is crucial to achieve a maximum tumour dose for an optimal treatment response, while min
Autor:
Maarten J. van der Doelen, Irma M. Oving, Dirk N. J. Wyndaele, Jean-Paul van Basten, Frederiek Terheggen, Addy C. M. van de Luijtgaarden, Wim. J. G. Oyen, W. Dick van Schelven, Franchette van den Berkmortel, Niven Mehra, Marcel J. R. Janssen, Judith B. Prins, Winald R. Gerritsen, José A. E. Custers, Inge M. van Oort
Publikováno v:
Prostate Cancer and Prostatic Diseases, 26, 1, pp. 142-150
Background Radium-223 is a registered treatment option for symptomatic bone metastatic castration-resistant prostate cancer (mCRPC). Aim of this multicenter, prospective observational cohort study was to evaluate health-related quality of life (HR-Qo